Last reviewed: June 5, 2026
Last updated: June 5, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic (semaglutide) has become widely discussed for weight management, even among people without diabetes. While clinical trials show significant weight reduction—patients lost an average of 15% of body weight over 68 weeks—the medication's original indication was blood sugar control in type 2 diabetes. Understanding the difference between on-label and off-label use, plus exploring personalized alternatives, helps you make an informed decision about GLP-1 therapy.
What Is Ozempic and How Does It Work for Weight Loss
Ozempic contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics an intestinal hormone regulating appetite and blood sugar. When semaglutide binds to GLP-1 receptors in the brain and gut, it slows stomach emptying, increases feelings of fullness, and reduces hunger signals. This mechanism explains why people taking the medication report eating smaller portions and feeling satisfied longer, leading to natural calorie reduction without strict dieting.
The drug's weight loss effect emerged during diabetes trials, where researchers noticed participants shed pounds independent of their baseline blood sugar levels. In the STEP trial series—specifically designed to study weight loss—adults without diabetes taking semaglutide lost 15–22% of their starting weight over one year, compared to 2–3% in the placebo group. This clinical evidence shifted conversations around GLP-1 use beyond diabetes management into the broader weight management landscape.
Off-Label Prescribing and FDA Status for Weight Loss
Ozempic itself is FDA-approved only for type 2 diabetes; it is not approved for weight loss in people without diabetes. However, off-label prescribing—using an FDA-approved drug for a non-approved indication—is legal and common in medical practice when a physician determines potential benefits outweigh risks. Many doctors prescribe Ozempic off-label for weight management because the clinical evidence supports its efficacy, and off-label use allows faster access than waiting for new FDA approvals.
A related medication, Wegovy (also semaglutide), received FDA approval specifically for chronic weight management in 2021, offering a legally sanctioned alternative for non-diabetic weight loss. Wegovy uses identical semaglutide but at different dosing schedules and carries explicit regulatory approval for weight management. For patients seeking medically supervised GLP-1 therapy without navigating off-label prescribing, compounded semaglutide from licensed pharmacies provides another pathway tailored to individual needs and genetic profiles.
Understanding Compounded Semaglutide vs. Brand-Name Options
Compounded semaglutide is manufactured by licensed 503A compounding pharmacies under strict quality standards and state pharmacy board oversight. These pharmacies prepare personalized medications in smaller batches, allowing flexibility in dosing and cost reductions compared to mass-produced brand-name versions. Compounded medications are not FDA-approved in the traditional sense; however, 503A compounding is a federally regulated practice for creating customized pharmaceuticals when medically appropriate.
PlexusDx partners exclusively with licensed 503A compounding pharmacies to deliver compounded semaglutide injections starting at $149 per month, with no insurance required and HSA/FSA eligibility. The same active ingredient in Ozempic is prepared under personalized protocols, often at a fraction of the cost. This approach makes GLP-1 therapy accessible to more people while maintaining pharmaceutical quality and medical oversight through PlexusDx's clinical team.
Personalization Through Genetic Testing and Precision Peptide Pathways
Not everyone responds equally to semaglutide. Genetic variations in GLP-1 receptor genes (like rs6923761), appetite regulation genes (FTO rs9939609), and other peptide pathways influence how effectively GLP-1 medications work for individual patients. PlexusDx's Precision Peptide Genetic Test identifies variants across 14 metabolic pathways and 49 peptides, revealing which mechanisms drive your weight gain and which therapies are likely to work best for your biology.
The test examines key genetic variants including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313—each affecting how your body processes hunger signals, satiety, and metabolic rate. With this genetic insight, PlexusDx physicians can recommend the optimal GLP-1 compound (semaglutide, tirzepatide, or dual therapies like GLP-Squared) and dosing strategy aligned to your peptide pathways. This genetic personalization transforms GLP-1 therapy from a one-size-fits-all approach into a precision protocol matched to your unique biology.
Side Effects, Safety Considerations, and Medical Supervision
Common side effects of GLP-1 medications include nausea, vomiting, diarrhea, and constipation—most often mild to moderate and declining over the first few weeks as the body adjusts. Rare but serious risks include pancreatitis, gallbladder issues, and retinopathy (eye problems), particularly in patients with existing diabetes complications. Medical supervision from a qualified physician is essential to monitor tolerance, screen for contraindications, and adjust therapy if side effects emerge or goals plateau.
Patients considering GLP-1 therapy should disclose a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2, as GLP-1 agonists carry a black-box warning in these populations. Dehydration from gastrointestinal side effects can complicate kidney function, especially in people with existing renal disease. PlexusDx conducts thorough health assessments before initiating therapy, monitors patients monthly, and adjusts protocols to maximize safety and tolerability alongside weight loss outcomes.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I take Ozempic just for weight loss without having diabetes?
Ozempic is FDA-approved for diabetes only, making weight-loss-only use off-label. However, off-label prescribing is legal and common when clinical evidence supports efficacy.
How much weight can I expect to lose with GLP-1 therapy?
Clinical trials show average weight loss of 15–22% of starting body weight over one year with semaglutide, though individual results vary based on genetics, lifestyle, and adherence.
Why is compounded semaglutide from PlexusDx cheaper than Ozempic or Wegovy?
PlexusDx compounded semaglutide is prepared by licensed 503A pharmacies without the marketing and distribution costs of brand-name drugs, allowing pricing starting at $149 per month. Your dose may increase over time for better results, but your monthly price stays fixed—no flat per-compound pricing hikes.
Is compounded semaglutide as safe and effective as FDA-approved versions?
Compounded semaglutide contains the same active ingredient and is manufactured under strict 503A pharmacy standards and state oversight. PlexusDx compounds are not FDA-approved as finished products, but the compounding process is federally regulated and medically supervised, making it a safe, effective, and more affordable option for most patients.
How does the Precision Peptide Genetic Test improve my GLP-1 results?
The test identifies 150+ genetic insights across 14 metabolic pathways, revealing whether GLP-1 receptors (rs6923761), appetite genes (FTO rs9939609), or other peptide systems drive your weight.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Do Side Effects of Semaglutide Go Away? Understanding Duration, Management, and What to Expect
How Much Weight Can I Lose With Ozempic?